ALSERES PHARMACEUTICALS INC Uncategorized Contracts & Agreements
52 Contracts & Agreements
- Navidea Biopharmaceuticals Enters into Option Agreement to LicenseParkinsons Disease Imaging Agent Licensing would add second neuro-imaging candidate to growing... (Filed With SEC on January 25, 2012)
- Alseres Pharmaceuticals, Inc (Filed With SEC on August 29, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on July 29, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on July 18, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on June 24, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on June 6, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on May 11, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on May 4, 2011)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2011)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2011)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on March 22, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on March 10, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on February 9, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on December 10, 2010)
- Alseres Pharmaceuticals, Inc (Filed With SEC on November 5, 2010)
- Entry into a Material Definitive Agreement (Filed With SEC on August 3, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- See Exhibit Index attached hereto (Filed With SEC on December 28, 2009)
- See Exhibit Index attached hereto (Filed With SEC on December 28, 2009)
- Exhibits See Exhibit Index attached hereto (Filed With SEC on October 2, 2009)
- EX-10.2 LETTER AGREEMENT CATO BIO VENTURES (Filed With SEC on February 27, 2009)
- Ex-10.1 Amendment No.9 to Manufacturing Agreement (Filed With SEC on December 8, 2008)
- Ex-10.1 Extension to Option Agreement, dated November 27, 2008 (Filed With SEC on December 3, 2008)
- EX-10.3 LETTER AGREEMENT ROBERT GIPSON (Filed With SEC on November 25, 2008)
- EXTENSION TO OPTION AGREEMENT (Filed With SEC on October 30, 2008)
- EX-10.1 Option Agreement dated May 2, 2008 (Filed With SEC on May 6, 2008)
- EX-10.1 - Amendment No. 8 dated 12-04-2007 to Manufacturing Agreement between MDS Nordion Inc. and the Company (Filed With SEC on December 7, 2007)
- EX-10.1 Amendment No. 7 dated as of December 7, 2006 (Filed With SEC on December 8, 2006)
- WITNESSETH: (Filed With SEC on November 14, 2005)
- - 2 - (Filed With SEC on November 14, 2005)
- ARTICLE I. DEFINITIONS (Filed With SEC on November 14, 2005)
